Skip to main content
Article thumbnail
Location of Repository

Loss of the Transcriptional Repressor PAG-3/Gfi-1 Results in Enhanced Neurosecretion that is Dependent on the Dense-Core Vesicle Membrane Protein IDA-1/IA-2

By Tao Cai, Hiroki Hirai, Tetsunari Fukushige, Ping Yu, Guofeng Zhang, Abner L. Notkins and Michael Krause

Abstract

It is generally accepted that neuroendocrine cells regulate dense core vesicle (DCV) biogenesis and cargo packaging in response to secretory demands, although the molecular mechanisms of this process are poorly understood. One factor that has previously been implicated in DCV regulation is IA-2, a catalytically inactive protein phosphatase present in DCV membranes. Our ability to directly visualize a functional, GFP-tagged version of an IA-2 homolog in live Caenorhabditis elegans animals has allowed us to capitalize on the genetics of the system to screen for mutations that disrupt DCV regulation. We found that loss of activity in the transcription factor PAG-3/Gfi-1, which functions as a repressor in many systems, results in a dramatic up-regulation of IDA-1/IA-2 and other DCV proteins. The up-regulation of DCV components was accompanied by an increase in presynaptic DCV numbers and resulted in phenotypes consistent with increased neuroendocrine secretion. Double mutant combinations revealed that these PAG-3 mutant phenotypes were dependent on wild type IDA-1 function. Our results support a model in which IDA-1/IA-2 is a critical element in DCV regulation and reveal a novel genetic link to PAG-3-mediated transcriptional regulation. To our knowledge, this is the first mutation identified that results in increased neurosecretion, a phenotype that has clinical implications for DCV-mediated secretory disorders

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2657203
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (1996). A genetic selection for Caenorhabditis elegans synaptic transmission mutants.
    2. (1992). A novel human insulinoma-associated cDNA, IA-1, encodes a protein with ‘‘zincfinger’’ DNA-binding motifs.
    3. (2006). Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay.
    4. (2006). Biogenesis of secretory granules.
    5. (1998). C. elegans neuroscience: genetics to genome.
    6. (1992). C. elegans unc-4 gene encodes a homeodomain protein that determines the pattern of synaptic input to specific motor neurons.
    7. (1995). Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase.
    8. (1997). Caenorhabditis elegans rab-3 mutant synapses exhibit impaired function and are partially depleted of vesicles.
    9. (1998). Control of alternative behavioral states by serotonin in Caenorhabditis elegans.
    10. (2003). daf-28 encodes a C. elegans insulin superfamily member that is regulated by environmental cues and acts in the DAF-2 signaling pathway.
    11. (2000). Dauer formation induced by high temperatures in Caenorhabditis elegans.
    12. (1995). Defective recycling of synaptic vesicles in synaptotagmin mutants of Caenorhabditis elegans.
    13. (2004). Dense core vesicle dynamics in Caenorhabditis elegans neurons and the role of kinesin UNC-104.
    14. (2006). Dense-core secretory granule biogenesis.
    15. (2001). Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion.
    16. (1998). Detection of chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a non-radioisotope oligonucleotide probe.
    17. (1983). Egg-laying defective mutants of the nematode Caenorhabditis elegans.
    18. (2001). Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
    19. (2007). Endocrine paraneoplastic syndromes in small cell lung carcinoma. Two case reports.
    20. (2004). Expression and regulation of an FMRFamide-related neuropeptide gene family in Caenorhabditis elegans.
    21. (2004). Functional genomic analysis of the ADP-ribosylation factor family of GTPases: phylogeny among diverse eukaryotes and function in C.
    22. (1996). Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor.
    23. (2004). Gfi/Pag-3/senseless zinc finger proteins: a unifying theme?
    24. (1999). Goalpha and diacylglycerol kinase negatively regulate the Gqalpha pathway in C.
    25. (2004). Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells.
    26. (1999). Growth hormonereleasing hormone: an autocrine growth factor for small cell lung carcinoma.
    27. (1996). IA-2, a transmembrane protein tyrosine phosphatase, is expressed in human lung cancer cell lines with neuroendocrine phenotype.
    28. (2001). IDA-1, a Caenorhabditis elegans homolog of the diabetic autoantigens IA-2 and phogrin, is expressed in peptidergic neurons in the worm.
    29. (1996). Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment.
    30. (2002). Immunologic and genetic factors in type 1 diabetes.
    31. (2004). Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice.
    32. (2004). Insulinoma-Associated Protein IA-2, a Vesicle Transmembrane Protein, Genetically Interacts with UNC-31/CAPS and Affects Neurosecre t i o ni nC a e n o r h a b d i t i se l e g a n s .
    33. (1996). Isacchi A
    34. (2007). Loss of GFI1 impairs pulmonary neuroendorine cell proliferation, but the neuroendocrine phenotype has limited impact on post-naphthalene airway repair.
    35. (1985). Mapping muscle protein genes by in situ hybridization using biotin-labeled probes.
    36. (1994). Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma.
    37. (1996). Molecular cloning of phogrin, a protein-tyrosine phosphatase homologue localized to insulin secretory granule membranes.
    38. (1999). Neuropeptide gene families in the nematode Caenorhabditis elegans.
    39. (2003). New aspects of neurotransmitter release and exocytosis: involvement of Ca2+/calmodulindependent phosphorylation of synapsin I in insulin exocytosis.
    40. (2004). Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in {beta}-cells.
    41. (2002). PAG-3, a Zn-finger transcription factor, determines neuroblast fate in C.
    42. (2007). PKA activation bypasses the requirement for UNC-31 in the docking of dense core vesicles from C. elegans neurons.
    43. (2007). PKC-1 regulates secretion of neuropeptides.
    44. (1977). Post-embryonic cell lineages of the nematode, Caenorhabditis elegans.
    45. (1999). Post-translational modifications of ICA512, a receptor tyrosine phosphatase-like protein of secretory granules.
    46. (2006). Presynaptic UNC31 (CAPS) is required to activate the G alpha(s) pathway of the Caenorhabditis elegans synaptic signaling network.
    47. (1998). Profile and differential expression of protein tyrosine phosphatases in mouse pancreatic islet tumor cell lines.
    48. (1993). Progression of interleukin-2 (IL-2)-dependent rat T cell lymphoma lines to IL-2-independent growth following activation of a gene (Gfi-1) encoding a novel zinc finger protein.
    49. (2001). Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map.
    50. (2001). Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverse C. elegans insulin gene family.
    51. (2001). Regulation of neurotransmitter vesicles by the homeodomain protein UNC-4 and its transcriptional corepressor UNC-37/groucho in Caenorhabditis elegans cholinergic motor neurons.
    52. (2004). Roles for two partially redundant alpha-tubulins during mitosis in early Caenorhabditis elegans embryos.
    53. (2000). Senseless, a Zn finger transcription factor, is necessary and sufficient for sensory organ development in Drosophila.
    54. (2000). Single nucleotide polymorphisms in wild isolates of Caenorhabditis elegans.
    55. Sudhof TC (2002) Molecular determinants of regulated exocytosis.
    56. (1993). Synaptic function is impaired but not eliminated in C. elegans mutants lacking synaptotagmin.
    57. (1998). Synaptic transmission deficits in Caenorhabditis elegans synaptobrevin mutants.
    58. (1997). Synaptic transmission. In: Riddle
    59. (1990). Synaptoporin, a novel putative channel protein of synaptic vesicles.
    60. (2006). Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5.
    61. (2004). Targeted disruption of the IA-2beta gene causes glucose intolerance and impairs insulin secretion but does not prevent the development of diabetes in NOD mice.
    62. (1997). The C. elegans gene pag-3 is homologous to the zinc finger proto-oncogene gfi-1.
    63. (2002). The C. elegans POU-domain transcription factor UNC-86 regulates the tph-1 tryptophan hydroxylase gene and neurite outgrowth in specific serotonergic neurons.
    64. (1999). The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors.
    65. (2005). The dense core transmembrane vesicle protein IA-2 is a regulator of vesicle number and insulin secretion.
    66. (2003). The EGL-21 carboxypeptidase E facilitates acetylcholine release at Caenorhabditis elegans neuromuscular junctions.
    67. (2001). The EGL-3 proprotein convertase regulates mechanosensory responses of Caenorhabditis elegans.
    68. (1993). The flp-1 propeptide is processed into multiple, highly similar FMRFamide-like peptides in Caenorhabditis elegans.
    69. (1974). The genetics of Caenorhabditis elegans.
    70. (2006). The growth factor independence-1 transcription factor: new functions and new insights.
    71. (2001). The IA-2 gene family: homologs in Caenorhabditis elegans, Drosophila and zebrafish.
    72. (2000). The Rab3 GDP/GTP exchange factor homolog AEX-3 has a dual function in synaptic transmission.
    73. (2007). The transcription factors Stat5a/b are not required for islet development but modulate pancreatic beta-cell physiology upon aging. Biochimica et biophysica acta 1773:
    74. (2002). The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the Cbl-associated protein.
    75. (2006). The zincfinger factor Insm1 (IA-1) is essential for the development of pancreatic beta cells and intestinal endocrine cells.
    76. (2000). Transmembrane protein tyrosine phosphatase IA-2 (ICA512) is expressed in human midgut carcinoids but is not detectable in normal enterochromaffin cells.
    77. (2008). unc-3-dependent repression of specific motor neuron fates in Caenorhabditis elegans.
    78. (2007). UNC-31 (CAPS) is required for dense-core vesicle but not synaptic vesicle exocytosis in Caenorhabditis elegans.
    79. (1995). Vesicle-associated membrane protein (VAMP)/synaptobrevin-2 is associated with dense core secretory granules in PC12 neuroendocrine cells.
    80. (2006). Zinc-finger transcription factor Gfi-1: versatile regulator of lymphocytes, neutrophils and hematopoietic stem cells.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.